BackPercheron Therapeutics Limited Overview

Percheron Therapeutics Limited Receivables

Track Percheron Therapeutics Limited's receivables ($960K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$962403.00
↓ 39.19% YoYΔ $-620119.00 vs prior year quarter

Peer trimmed avg / median

Loading

Percheron Therapeutics Limited Receivables History

Loading

Percheron Therapeutics Limited vs. peers: Receivables Comparison

Loading

Percheron Therapeutics Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Percheron Therapeutics Limited (PER.AX) FAQ

Percheron Therapeutics Limited's receivables stands at $960K as of June 2026. That compares with $1.6M in the prior-year period — down 39.2% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Percheron Therapeutics Limited reported $960K in receivables versus $1.6M a year earlier — a 39.2% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $1.6M in the prior-year period — down 39.2% year over year. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Percheron Therapeutics Limited's receivables evolved across reporting periods, while the comparison chart places PER.AX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.